Publications by Dr Joyce Nutt - ePrints

Browsing publications by Dr Joyce Nutt.

Newcastle Authors	Title	Year
Professor Ruth Plummer Dr Jane Margetts Professor John Lunec Dr Joyce Nutt	Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non-Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker	2015
Dr Joyce Nutt Kieran O'Toole Dr Fiona Black Mike Cole Professor Ruth Plummer et al.	Expression of methylthioadenosine phosphorylase (MTAP) in malignant pleural mesothelioma (MPM) and its implication for pemetrexed-based chemotherapy	2010
Dr Joyce Nutt Kieran O'Toole Dr Fiona Black Amy Quinn Professor Alan Calvert et al.	The role of folate receptor alpha (FR alpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy	2010
Dr Joyce Nutt Kieran O'Toole Dr Fiona Black Professor Ruth Plummer Professor Alan Calvert et al.	Expression of folate receptor alpha (FRa) in malignant pleural mesothelioma patients by immunohistochemistry: a clinico-pathological analysis	2009
Dr Joyce Nutt Kieran O'Toole Professor John Lunec	Growth inhibition by tyrosine kinase inhibitors in mesothelioma cell lines	2009
Dr Joyce Nutt Professor John Lunec	The wide variation in response of mesothelioma cell lines to pemetrexed and lack of relationship to presence of folate receptor alpha (Fra)	2009
Dr Joyce Nutt Kilian Mellon Professor John Lunec	hEGR1 is induced by EGF, inhibited by gefitinib in bladder cell lines and related to EGF receptor levels in bladder tumours	2007
Dr Joyce Nutt Henry Lazarowicz Kilian Mellon Professor John Lunec	Gefitinib ('Iressa', ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2	2004
Garrett Durkan Dr Joyce Nutt Colin Marsh Dr Mary Robinson Professor David Neal et al.	Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer	2003
Dr Joyce Nutt Garrett Durkan Kilian Mellon Professor John Lunec	Matrix metalloproteinases (MMPs) in bladder cancer: The induction of MMP9 by epidermal growth factor and its detection in urine	2003
Garrett Durkan Dr Joyce Nutt Professor David Neal Professor John Lunec Kilian Mellon et al.	Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder	2001
Dr Joyce Nutt Garrett Durkan Professor John Lunec	Matrixmetalloproteinase stimulation in bladder tumour cell lines and elevated levels in the urine of bladder tumour patients.	1999
Dr Joyce Nutt Kilian Mellon Dr Khaver Qureshi Professor John Lunec	Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours	1998
Dr Joyce Nutt Professor John Lunec	Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cells	1996
Dr Joyce Nutt Professor John Lunec	Phorbal ester and bryostatin effects on growth and the expression of estrogen and TGF-beta in breast-tumor cells	1991
Dr Joyce Nutt Professor John Lunec	Effects of estradiol, TPA and bryostatin on growth, the transcriptional regulation of estrogen responsive genes and the expression of TGF-beta in human breast tumor-lines	1990
Dr Joyce Nutt Professor John Lunec	Interactive effects of estradiol, TPA and bryostatin on growth and on the expression of estrogen responsive genes and TGF-beta in human breast tumor lines	1990
Gwyn Pyle Dr Joyce Nutt	Thyroid stimulating immunoglobulins and control of thyroid function	1976